Cargando…

Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients

Severe lupus nephritis in the absence of systemic lupus erythematosus (SLE) is a rare condition with an unclear clinical presentation and outcome. We conducted a historical observational study of 12 adult (age >18 years) patients with biopsy-proven severe lupus nephritis or lupus-like nephritis w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Touzot, Maxime, Terrier, Cécile Saint-Pastou, Faguer, Stanislas, Masson, Ingrid, François, Hélène, Couzi, Lionel, Hummel, Aurélie, Quellard, Nathalie, Touchard, Guy, Jourde-Chiche, Noémie, Goujon, Jean-Michel, Daugas, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	3600
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728820/ https://www.ncbi.nlm.nih.gov/pubmed/29310419 http://dx.doi.org/10.1097/MD.0000000000009017

Ejemplares similares

Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis
por: Jarrot, Pierre-Andre, et al.
Publicado: (2016)

Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
por: Jourde-Chiche, Noémie, et al.
Publicado: (2023)

Urinary Peptides as Potential Non-Invasive Biomarkers for Lupus Nephritis: Results of the Peptidu-LUP Study
por: Tailliar, Maxence, et al.
Publicado: (2021)

Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial
por: Jourde-Chiche, Noemie, et al.
Publicado: (2022)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

Construction of molecular subgroups in childhood systemic lupus erythematosus using bioinformatics
por: Ma, Jianglei, et al.
Publicado: (2022)

Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network
por: Fernández-Garcés, Mar, et al.
Publicado: (2019)

Intestinal Pseudo-Obstruction in Systemic Lupus Erythematosus: A Case Report and Review of the Literature
por: Wang, Jian-lin, et al.
Publicado: (2014)

Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus
por: Wang, Yanping, et al.
Publicado: (2020)

Clinical efficacy and safety of sirolimus in childhood-onset systemic lupus erythematosus in real world
por: Zhang, Lei, et al.
Publicado: (2022)

Serum Cyr61 is Associated With Clinical Disease Activity and Inflammation in Patients With Systemic Lupus Erythematosus
por: Lin, Jinpiao, et al.
Publicado: (2015)

Thymoma with systemic lupus erythematosus and immune-related anemia: A case of thymoma with SLE and IRA
por: Zhang, Huayang, et al.
Publicado: (2022)

Association between lymphocyte subsets and cytomegalovirus infection status among patients with systemic lupus erythematosus: A pilot study
por: Qin, Ling, et al.
Publicado: (2019)

Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review
por: Chang, En-Shuo, et al.
Publicado: (2022)

Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients
por: Audemard-Verger, Alexandra, et al.
Publicado: (2016)

Pseudo-pseudo Meigs’ syndrome presenting with a combination of polyserositis, elevated serum CA 125 in systemic lupus erythematosus: A case report
por: Gao, Fei, et al.
Publicado: (2019)

Hematopoietic stem cell transplantation in an infant with dedicator of cytokinesis 8 (DOCK8) deficiency associated with systemic lupus erythematosus: A case report
por: Seo, Euri, et al.
Publicado: (2021)

Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis
por: Liang, Hui-ling, et al.
Publicado: (2017)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption
por: Štambuk, Sandra Karanović, et al.
Publicado: (2023)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series
por: Ebbo, Mikael, et al.
Publicado: (2017)

Sarcoidosis Occurring After Lymphoma: Report of 14 Patients and Review of the Literature
por: London, Jonathan, et al.
Publicado: (2014)

Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus
por: Plawecki, Maëlle, et al.
Publicado: (2016)

New treatment options for lupus – a focus on belimumab
por: Chiche, Laurent, et al.
Publicado: (2012)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
por: Chen, Dong-Ni, et al.
Publicado: (2018)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
por: Olson, S. W., et al.
Publicado: (2017)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012)

Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis
por: Gonzalo, Elena, et al.
Publicado: (2012)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial
por: Galbraith, Lauren, et al.
Publicado: (2014)

Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial
por: Gheet, Fatma Sayed, et al.
Publicado: (2023)

Long-term renal outcomes of patients with non-proliferative lupus nephritis
por: Kang, Eun-Song, et al.
Publicado: (2023)

BASOPHILS AND THE T HELPER 2 ENVIRONMENT CAN PROMOTE THE DEVELOPMENT OF LUPUS NEPHRITIS
por: Charles, Nicolas, et al.
Publicado: (2010)

Basophils contribute to pristane-induced Lupus-like nephritis model
por: Dema, Barbara, et al.
Publicado: (2017)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
por: Kanodia, Kamal V, et al.
Publicado: (2008)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
por: Häyry, Aliisa, et al.
Publicado: (2022)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
por: Marín-Rosales, Miguel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1abh4jcqcqnhgvau3b8bsafh7b